Biotech and Pharmaceuticals
Pfizer deal will help expand reach of migraine pill Nurtec, Biohaven CEO says
Pfizer’s purchase of migraine medication maker Biohaven Pharmaceutical represents a commitment to expand the reach of its calcitonin gene-related peptide (CGRP) franchise, CEO Vlad Coric told CNBC’s Jim Cramer on Tuesday. “There are still over 300,000 physicians in the U.S who write for the older triptans and have not yet written for one oral CGRP,” […]
Read More
U.S. gun homicides reached highest level in 25 years during Covid pandemic, CDC says
Gun homicides in the U.S. reached their highest level in more than 25 years during the Covid-19 pandemic, according to the Centers for Disease Control and Prevention. Homicides from guns rose 35% during the first year of the pandemic to the highest level since 1994, according to a CDC Morbidity and Mortality Weekly report published […]
Read More
An Oklahoma abortion clinic was a safe haven for women fleeing Texas ban. It will shut down if Roe falls
A surgical tech and recovery room staff member, walk a patient from Texas to the recovery room following her abortion at the Trust Women clinic in Oklahoma City, U.S., December 6, 2021. Evelyn Hockstein | Reuters The Tulsa Women’s Clinic, one of four abortion providers in Oklahoma, might have to shut down completely as soon […]
Read More
Novavax posts first profitable quarter as Covid vaccine rolls out around the world
Rafael Henrique | LightRocket | Getty Images Novavax on Monday reported its first profitable quarter as its Covid vaccine rolls out across several countries around the world, though the company still missed earnings and revenue expectations. Novavax stock was down more than 8% in after hours trading. Novavax reported net income of $203 million in […]
Read More
U.S. will limit next generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding
The U.S. will have to limit the next generation of Covid vaccines this fall to individuals at the highest risk of getting seriously sick from the virus if Congress fails to approve funding to purchase the new shots, according to a senior Biden administration official. The official, who spoke on condition of anonymity, warned that […]
Read More
CDC investigating 109 cases of severe hepatitis in children across 25 states and territories, including 5 deaths
The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters The Centers for Disease Control and Prevention is investigating 109 cases of severe hepatitis, including five deaths, the public health agency said on Friday. Ninety percent of the children were hospitalized and 14% required liver transplants, according to the […]
Read More
New York City could bring back Covid mask mandate, vaccine checks if hospitals come under pressure
Children are seen walking to school, on the first day of lifting the indoor mask mandate for DOE schools between K through 12, in Brooklyn, New York City, New York, U.S. March 7, 2022. Brendan McDermid | Reuters New York City could bring back mask mandates and proof of vaccination status to go to restaurants, […]
Read More
Moderna blows out first-quarter earnings expectations, triples Covid vaccine sales
The Moderna Covid-19 vaccine awaits administration at a vaccination clinic in Los Angeles, California on December 15, 2021. Frederic J. Brown | AFP | Getty Images Moderna sold $5.9 billion of its Covid vaccine in the first quarter, blowing out revenue and profit expectations. The biotech company’s shares soared by more than 8% in premarket […]
Read More
Paxlovid prescriptions to treat Covid increased tenfold in U.S. since late February, Pfizer says
Pfizer on Tuesday said prescriptions for its oral antiviral to treat Covid-19 have increased tenfold in the U.S. since late February, as more pharmacies and other locations receive supply. CEO Albert Bourla, in an earnings call Tuesday morning, said nearly 80,000 patients were treated with Paxlovid in the U.S. the week ending April 22, up […]
Read More
Pfizer reports combined sales of $15 billion for Covid vaccine and antiviral treatment in first quarter
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer beat on its top and bottom line in its first quarter earnings report, driven by strong sales of its Covid vaccine and oral antiviral treatment. The pharmaceutical giant […]
Read More